342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors. (September 2015) - Juric, D.; Rodón, J.; Bauer, T.M.; Wainberg, Z.; Tolaney, S.; Modi, S.; Martín, A. González; Hengelage, T.; Melendez, M.; Choudhury, S.; Nauwelaerts, H.; Bedard, P.L.